Medicare obesity drug trial opens $50-a-month access to millions

The 18-month program creates the first Medicare-only pathway for weight-loss coverage, with KFF estimating nearly 4 million people could qualify and analysts seeing billions in added drug sales.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.